View Item 

Show simple item record

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes
dc.contributor.authorLentine, K. L.
dc.contributor.authorLam, N. N.
dc.contributor.authorNaik, A. S.
dc.contributor.authorAxelrod, D. A.
dc.contributor.authorZhang, Z.
dc.contributor.authorDharnidharka, V. R.
dc.contributor.authorHess, G. P.
dc.contributor.authorSegev, D. L.
dc.contributor.authorOuseph, R.
dc.contributor.authorRandall, H.
dc.contributor.authorAlhamad, T.
dc.contributor.authorDevraj, R.
dc.contributor.authorGadi, R.
dc.contributor.authorKasiske, B. L.
dc.contributor.authorBrennan, D. C.
dc.contributor.authorSchnitzler, M. A.
dc.date.accessioned2018-12-06T17:37:55Z
dc.date.available2020-01-09T19:40:14Zen
dc.date.issued2018-12
dc.identifier.citationLentine, K. L.; Lam, N. N.; Naik, A. S.; Axelrod, D. A.; Zhang, Z.; Dharnidharka, V. R.; Hess, G. P.; Segev, D. L.; Ouseph, R.; Randall, H.; Alhamad, T.; Devraj, R.; Gadi, R.; Kasiske, B. L.; Brennan, D. C.; Schnitzler, M. A. (2018). "Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes." American Journal of Transplantation 18(12): 2987-2999.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/146648
dc.publisherWiley Periodicals, Inc.
dc.subject.otherepidemiology
dc.subject.otherclinical research/practice
dc.subject.otherScientific Registry for Transplant Recipients (SRTR)
dc.subject.otherkidney transplantation/nephrology
dc.titlePrescription opioid use before and after kidney transplant: Implications for posttransplant outcomes
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146648/1/AJT14714-sup-0001-AppendixS1.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146648/2/ajt14714_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146648/3/ajt14714.pdf
dc.identifier.doi10.1111/ajt.14714
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferenceWeisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005; 16 ( 8 ): 2487 ‐ 2494.
dc.identifier.citedreferenceDew MA, Switzer GE, DiMartini AF, Matukaitis J, Fitzgerald MG, Kormos RL. Psychosocial assessments and outcomes in organ transplantation. Prog Transplant. 2000; 10 ( 4 ): 239 ‐ 259; 260–231.
dc.identifier.citedreferencePham PT, Pham PA, Pham PC, Parikh S, Danovitch G. Evaluation of adult kidney transplant candidates. Semin Dial. 2010; 23 ( 6 ): 595 ‐ 605.
dc.identifier.citedreferenceLentine KL, Kasiske BL, Levey AS, et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation. 2017; 101 ( 8S suppl 1 ): S1 ‐ S109.
dc.identifier.citedreferenceManchikanti L, Helm 2nd S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012; 15 ( 3 suppl ): ES9 ‐ ES38.
dc.identifier.citedreferenceBohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose‐related deaths. JAMA. 2011; 305 ( 13 ): 1315 ‐ 1321.
dc.identifier.citedreferenceDrash W, Merica D. President Trump declares opioid crisis a national emergency. CNN Health News, August 11, 2017. http://www.cnn.com/2017/08/10/health/trump-opioid-emergency-declaration-bn/index.html. Accessed September 30, 2017.
dc.identifier.citedreferencePullen LC. The opioid epidemic weaves its way through the transplant community. Am J Transp. 2017; 17 ( 9 ): 2231 ‐ 2232.
dc.identifier.citedreferenceNIH Director Francis Collins on America’s opioid crisis. Washington Post Live. September 20, 2017. https://www.washingtonpost.com/video/postlive/nih-directorfrancis-collins-on-opioid-crisis-in-the-us/2017/09/20/cfb04e68-9e41-11e7-b2a7-bc70b6f98089_video.html?utm_term=.9ef48436a9d8. Accessed September 30, 2017.
dc.identifier.citedreferenceMenendez ME, Ring D, Bateman BT. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res. 2015; 473 ( 7 ): 2402 ‐ 2412.
dc.identifier.citedreferenceCron DC, Englesbe MJ, Bolton CJ, et al. Preoperative opioid use is independently associated with increased costs and worse outcomes after major abdominal surgery. Ann Surg. 2016; 265: 695 ‐ 701.
dc.identifier.citedreferenceRandall HB, Alhamad T, Schnitzler MA, et al. Survival implications of opioid use before and after liver transplantation. Liver Transp. 2017; 23 ( 3 ): 305 ‐ 314.
dc.identifier.citedreferenceLentine KL, Lam NN, Schnitzler MA, et al. Predonation prescription opioid use: a novel risk factor for readmission after living kidney donation. Am J Transp. 2017; 17 ( 3 ): 744 ‐ 753.
dc.identifier.citedreferenceDean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004; 28 ( 5 ): 497 ‐ 504.
dc.identifier.citedreferenceNiscola P, Scaramucci L, Vischini G, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010; 11 ( 6 ): 752 ‐ 758.
dc.identifier.citedreferenceLentine KL, Yuan H, Tuttle‐Newhall JE, et al. Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data. Transplantation. 2015; 99 ( 1 ): 187 ‐ 196.
dc.identifier.citedreferenceLentine KL, Lam NN, Xiao H, et al. Associations of pre‐transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol. 2015; 41 ( 2 ): 165 ‐ 176.
dc.identifier.citedreferenceKimmel PL, Fwu CW, Abbott KC, Eggers AW, Kline PP, Eggers PW. Opioid prescription, morbidity, and mortality in United States dialysis patients. J Am Soc Nephrol. 2017; 28: 3658 ‐ 3670.
dc.identifier.citedreferenceBarrantes F, Luan FL, Kommareddi M, et al. A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk. Kidney Int. 2013; 84 ( 2 ): 390 ‐ 396.
dc.identifier.citedreferenceSalisbury EM, Game DS, Al‐Shakarchi I, et al. Changing practice to improve pain control for renal patients. Postgrad Med J. 2009; 85 ( 999 ): 30 ‐ 33.
dc.identifier.citedreferenceBailie GR, Mason NA, Bragg‐Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int. 2004; 65 ( 6 ): 2419 ‐ 2425.
dc.identifier.citedreferenceDavison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003; 42 ( 6 ): 1239 ‐ 1247.
dc.identifier.citedreferenceKurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis. 2003; 42 ( 2 ): 217 ‐ 228.
dc.identifier.citedreferenceMasajtis‐Zagajewska A, Pietrasik P, Krawczyk J, et al. Similar prevalence but different characteristics of pain in kidney transplant recipients and chronic hemodialysis patients. Clin Transplant. 2011; 25 ( 2 ): E144 ‐ E151.
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Heroin overdose deaths increased in many states through 2012. https://www.cdc.gov/media/releases/2014/p1002-heroin-overdose.html (released October 4, 2014). Accessed May 11, 2016.
dc.identifier.citedreferenceWollschlaeger BA, Willson TM, Montejano LB, Ronquest NA, Nadipelli VR. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse. J Opioid Manag. 2017; 13 ( 4 ): 207 ‐ 220.
dc.identifier.citedreferenceCampbell CI, Kline‐Simon AH, Von Korff M, Saunders KW, Weisner C. Alcohol and drug use and aberrant drug‐related behavior among patients on chronic opioid therapy. Subst Use Misuse. 2017; 52 ( 10 ): 1283 ‐ 1291.
dc.identifier.citedreferenceScientific Registry of Transplant Recipients (SRTR). Risk Adjustment Models. https://www.srtr.org/reports-tools/risk-adjustment-models-posttransplant-outcomes/. Accessed January 20, 2018.
dc.identifier.citedreferenceLevy AR, O’Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003; 10 ( 2 ): 67 ‐ 71.
dc.identifier.citedreferenceLau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997; 50 ( 5 ): 619 ‐ 625.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
AJT14714-sup-0001-AppendixS1.pdf
Size:
379.2KB
Format:
PDF
View/Open
Name:
ajt14714_am.pdf
Size:
28.82MB
Format:
PDF
View/Open
Name:
ajt14714.pdf
Size:
462.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.